Matricelf

MatricelfMatricelf
Matricelf

Matricelf

Develops autologous engineered tissue from omentum biopsies for medical conditions.

Website
DR 282019Active20Tel Aviv, Israel
Rate
Advertise here

About

Matricelf is developing a revolutionary regenerative medicine platform to treat spinal cord injury (SCI) and other medical conditions like stroke and traumatic brain injury. Their proprietary technology engineers functional neural implants using a patient's own induced pluripotent stem cells (iPSCs) differentiated within a personalized extracellular matrix (ECM) hydrogel. This approach aims to restore lost function by bridging damaged spinal tissue with reduced rejection risk.
Frequently asked

What does Matricelf do?

Matricelf is developing a revolutionary regenerative medicine platform to treat spinal cord injury (SCI) and other medical conditions like stroke and traumatic brain injury. Their proprietary technology engineers functional neural implants using a patient's own induced pluripotent stem cells (iPSCs) differentiated within a personalized extracellular matrix (ECM) hydrogel. This approach aims to restore lost function by bridging damaged spinal tissue with reduced rejection risk.

What is Matricelf's revenue?

StartupHub estimates Matricelf's annual revenue at $3.3M (range $1.9M to $5.3M, 64% confidence), based on comparable companies in the sector.

Where is Matricelf headquartered?

Matricelf is headquartered in Tel Aviv, Israel.

When was Matricelf founded?

Matricelf was founded in 2019.

What industry does Matricelf operate in?

Matricelf operates in Life Sciences, Biotech, MedTech, HealthTech, Tissue Engineering, Regenerative Medicine.

How many employees does Matricelf have?

Matricelf has approximately 20 people on record.

HEADCOUNT
20
DOMAIN RATING
28
Comments

No comments yet. Be the first to share your take.